Peter G. Shields mainly investigates Internal medicine, Genotype, Odds ratio, Endocrinology and Allele. His Internal medicine research includes elements of Smoking cessation, Bupropion and Oncology. His Genotype research incorporates elements of Cancer and Lung cancer.
His study in Lung cancer is interdisciplinary in nature, drawing from both Lung cancer susceptibility and Genetics, Carcinogen. The various areas that Peter G. Shields examines in his Odds ratio study include Case-control study, Confidence interval and Risk factor. His Allele research integrates issues from Immunology, Nitric oxide synthase, Genetic predisposition and Restriction fragment length polymorphism.
The scientist’s investigation covers issues in Internal medicine, Oncology, Breast cancer, Cancer and Genotype. He regularly links together related areas like Endocrinology in his Internal medicine studies. His research in Breast cancer tackles topics such as DNA methylation which are related to areas like Epigenetics.
Peter G. Shields has researched Cancer in several fields, including Immunology, Bioinformatics and Pathology. His Genotype study combines topics from a wide range of disciplines, such as Allele and Genetic predisposition. The Odds ratio study combines topics in areas such as Confidence interval and Risk factor.
Peter G. Shields mainly focuses on Internal medicine, Oncology, Cancer, Lung cancer and Cancer research. His research in Oncology intersects with topics in Adverse effect, Incidence and Immune checkpoint inhibitors, Immunotherapy. His work carried out in the field of Cancer brings together such families of science as Electronic cigarette, Transcriptome, Stage III Non-Small Cell Lung Cancer and Nicotine.
Peter G. Shields usually deals with Nicotine and limits it to topics linked to Environmental health and Quartile and Perceived harm. His studies in Lung cancer integrate themes in fields like Exact test, Generalized anxiety disorder, Depression, Anxiety and Hazard ratio. His Cancer research study combines topics in areas such as Exome sequencing, Inflammasome and Tumor microenvironment.
His scientific interests lie mostly in Internal medicine, Oncology, Cancer research, Extramural and Bronchoalveolar lavage. His Internal medicine study frequently links to adjacent areas such as Nicotine gum. His Oncology research includes themes of Clinical trial, KRAS, Colorectal cancer, DPYD and Immunotherapy.
His research investigates the connection between Clinical trial and topics such as Propensity score matching that intersect with issues in Cancer. He interconnects Carcinogenesis and Epidermal growth factor receptor in the investigation of issues within Cancer research. As a part of the same scientific family, Peter G. Shields mostly works in the field of Bronchoscopies, focusing on Physiology and, on occasion, Breast cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Metabolic gene polymorphism frequencies in control populations.
S. Garte;L. Gaspari;A.K. Alexandrie;C. Ambrosone.
Cancer Epidemiology, Biomarkers & Prevention (2001)
Frequent Nitric Oxide Synthase-2 Expression in Human Colon Adenomas: Implication for Tumor Angiogenesis and Colon Cancer Progression
Stefan Ambs;William G. Merriam;William P. Bennett;Emanuela Felley-Bosco.
Cancer Research (1998)
Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease.
S P Hussain;P Amstad;K Raja;S Ambs.
Cancer Research (2000)
Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI
Benjamin C Blount;Mateusz P Karwowski;Peter G Shields;Maria Morel-Espinosa.
The New England Journal of Medicine (2020)
Manganese Superoxide Dismutase (MnSOD) Genetic Polymorphisms, Dietary Antioxidants, and Risk of Breast Cancer
Christine B. Ambrosone;Jo L. Freudenheim;Patricia A. Thompson;Elise Bowman.
Cancer Research (1999)
Evidence suggesting the role of specific genetic factors in cigarette smoking.
Caryn Lerman;Neil E. Caporaso;Janet Audrain;David Main.
Health Psychology (1999)
Cigarette Smoking, N-Acetyltransferase 2 Genetic Polymorphisms, and Breast Cancer Risk
Christine B. Ambrosone;Jo L. Freudenheim;Saxon Graham;James R. Marshall.
Genetic polymorphisms in DNA repair genes and risk of lung cancer
Dorota Butkiewicz;Marek Rusin;Lindsey Enewold;Peter G. Shields.
Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.
Rachel Pearlman;Wendy L Frankel;Benjamin Swanson;Weiqiang Zhao.
JAMA Oncology (2017)
Breast Cancer Risk in Premenopausal Women Is Inversely Associated with Consumption of Broccoli, a Source of Isothiocyanates, but Is Not Modified by GST Genotype
Christine B. Ambrosone;Susan E. McCann;Jo L. Freudenheim;Jo L. Freudenheim;James R. Marshall.
Journal of Nutrition (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: